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As the fields of tissue engineering and regenerative medicine mature towards clinical applications the need for on-line 
monitoring, both for quantitative and qualitative use, becomes essential. Resazurin based metabolic assays are frequently 
applied for determining cytotoxicity and have shown great potential for monitoring 3D bioreactor facilitated cell culture. 
However, no quantitative correlation between the metabolic conversion rate of resazurin and cell number has been defined 
yet. In this work we determined conversion rates of Presto Blue™, a resazurin based metabolic assay, for human periosteal 
cells during 2D and 3D static and 3D perfusion culture. Our results showed that for the evaluated culture systems there is 
a quantitative correlation between the Presto Blue™ conversion rate and the cell number during the expansion phase, with 
no influence of the perfusion related parameters i.e. flow rate and shear stress. The correlation between cell number and 
Presto Blue™ conversion subsequently enabled the definition of operating windows for optimal signal readouts. In 
conclusion, our data showed that the conversion of the resazurin based Presto Blue™ metabolic assay can be used as a 
quantitative read-out for on-line monitoring of cell proliferation in a 3D perfusion bioreactor system although a system 
specific validation is required. 
1.1. Introduction 
The development of cell based tissue engineering strategies for the repair or replacement of damaged organs and tissues is 
a rapidly evolving research field (Martin et al. 2011, Martin et al. 2012).  As these novel cell-based therapies fall under the 
definition of the ‘Advanced Therapy Medicinal Products’ (ATMPs) of the European Medicine’s Agency (EMA), the 
application of the Process Analytical Technology guidelines (PAT) to develop well characterised products by designing 
and controlling the manufacturing process through timely measurements of critical quality attributes is essential (Chew et 
al. 2010, Rebulla et al. 2010, Schneider et al. 2010). The integration of bioreactor systems in current lab scale processes 
therefore holds promise for the translation in a clinical and ultimately commercial setting (Martin et al. 2010, Salter et al. 
2012). Bioreactors have been employed frequently to provide sufficient  nutrient and oxygen transport and removal of 
waste products (Grayson et al. 2004, Martin et al. 2004, Haycock 2011, Rodrigues et al. 2011, Jakob et al. 2012, Salter et 
al. 2012) while allowing for monitoring and control of physicochemical and biological parameters (Tsao et al. 2005, Das 
et al. 2010, Martin et al. 2010, Rauh et al. 2011, Santoro et al. 2012, Zhou et al. 2013) during cell proliferation, 
differentiation and the development of a cell-carrier constructs. Furthermore these parameters could be used as non-
destructive quality indicators of the cells or the developing construct. 
Since in vitro proliferation is an essential process step for the production of cell based products (Rodrigues et al. 2011), 
on-line measurements of metabolic activity parameters such as glucose, lactate and oxygen concentration, could allow for 
a non-destructive assessment of the quality of the 3D cell culture (Tsao et al. 2005, Das et al. 2010, Santoro et al. 2012, 
Frese et al. 2014). Although, for example, correlating a decrease in oxygen concentration to cell proliferation has been 
shown to be a viable strategy to monitor proliferation for high cell numbers (Santoro et al. 2012), these techniques often 
fall short when lower cell numbers in the order of magnitude 104 to 106 cells need to be monitored and quantified (Zhou et 
al. 2013). Limited sensor sensitivity as well as low oxygen and glucose consumption rates per cell hamper the reliability 
of such measurements (Zhou et al. 2013). Therefore alternate methodologies to monitor cell number, viability and 
proliferation as well as differentiation in bioreactors are essential, especially for the initial crucial expansion steps (post 
biopsy expansion) of scarce adult stem cell populations.  
Metabolic assays such as the tetrazolium based 3-[4-5-Dimethylthiazol-2-yl]-2-5-diphenyl bromide tetrazolium bromide 
(MTT) and the resazurin based Alamar Blue® assay (AB) use the redox activity of the cells to qualitatively monitor cell 
populations based on the generation of an optical or fluorescent detectable component (Nociari et al. 1998, Back et al. 
1999, Quent et al. 2010, Uzunoglu et al. 2010, Rampersad 2012, Mueller et al. 2013). MTT and other tetrazolium based 
assays are based on the cleavage and reduction of the tetrazolium ring to blue formazan crystals by the mitochondrial 
dehydrogenases (Nociari et al. 1998, Quent et al. 2010). These crystals can be solubilised and quantified in the cell lysate 
as a measure for metabolic cell activity. Despite the frequent use of these assays the fact that this methodology can only be 
used as an endpoint analysis is a serious disadvantage (Quent et al. 2010). The resazurin based AB and Presto Blue® (PB) 
assays on the other hand use the mitochondrial activity to reduce the non-fluorescent, blue resazurin to the fluorescent, 
pink resorufin (Nociari et al. 1998, O'Brien et al. 2000, Quent et al. 2010). This non-toxic, water soluble dye enables 
continuous cell culture monitoring and has been shown to be a powerful tool to assess cell viability and proliferation in 
both static and dynamic 3D setups (Gloeckner et al. 2001, Cui et al. 2007, Mueller et al. 2013, Zhou et al. 2013). These 
reports show a clear correlation between the obtained fluorescent signal and the cell number. However, contradictory results 
showing discrepancies between cell number and the metabolic conversion of the resazurin when using static culture systems 
are also present, indicating that the performance of these assays is dependent on the cell type, culture and measurement 
setup (Ng et al. 2005, Quent et al. 2010). 
In order to determine whether the quantitative use of a resazurin based assay in a bioreactor setup is possible, the influence 
of the cell culture method and measurement setup on the conversion rate of the resazurin and on the metabolic activity of 
the cells has to be known. The redox activity of a cultured cell population was already shown to be influenced by long term 
proliferation and the induction of differentiation (Rice et al. 2010, Quinn et al. 2012). The influence of different culture 
systems and parameters on the metabolic activity of the cells and the conversion rate of the metabolic assays is however 
not known, which hampers the quantitative use of these methods. 
In this work we used the PB metabolic assay to monitor and quantify cell proliferation in a perfusion bioreactor setup up 
to 21 days. At first, the influence of different culture setups was investigated by measuring the metabolic activity of cells 
cultured in 2D and in 3D static and 3D perfusion bioreactor setups, and correlating this to DNA content. Subsequently a 
dynamic monitoring method was developed to overcome diffusion limitations that were observed when 3D scaffolds were 
measured in a static setup, affecting the conversion rate. Finally, the influence of perfusion flow rate and shear stress on 
the conversion of the metabolic assay was determined by using medium with different viscosities. Based on DNA 
measurements conversion rates for the PB assay in the different setups were found to enable the quantitative monitoring of 
cell proliferation.  
1.2. Materials and Methods 
1.2.1. Human Periosteal Derived cells (hPDCs)  
hPDCs were isolated from periosteal biopsies obtained from 4 different donors (age 11, 13, 14 and 17, equal distribution 
of gender) as described previously and pooled for further use (Eyckmans et al. 2006). This procedure was approved by the 
ethics committee for Human Medical Research (KU Leuven) and performed with patient informed consent. hPDCs were 
expanded in Dulbecco’s modified Eagle’s medium with high-glucose (Life Technologies) containing 10% foetal bovine 
serum (Gibco), 1% sodium pyruvate (Life Technologies) and 1% antibiotic–antimycotic (100 units/mL penicillin, 
100mg/mL streptomycin, and 0.25 mg/mL amphotericin B; Life Technologies), further mentioned as culture medium. The 
cells were seeded at 5,700 cells/cm² and passaged at 80%–90% confluency. Cell expansion and 2D experiments were 
performed in standard cell culture conditions (relative humidity: 95%, 5%CO2, 37°C) 
1.2.2. Ti6Al4V scaffolds 
For 3D cell culture, additive manufactured Ti6Al4V scaffolds (Ø = 6 mm, h = 6 mm) (Van Bael et al. 2011, Pyka et al. 
2012) were used as described before (Papantoniou et al. 2014). The total volume of the scaffolds was 166 ± 3 mm³, the 
available volume 130 ± 5 mm³ and the available surface 7.5 ± 0.6 mm² as determined with nanoCT (Kerckhofs et al. 2013). 
Briefly, scaffolds were ultrasonically cleansed prior to use in acetone, ethanol and distilled water for 10 minutes each after 
which they received an alkaline treatment with 5M sodium hydroxide for 24 hours at 60°C. Subsequently, scaffolds were 
rinsed with distilled water after which they were sterilised in a steam autoclave. Prior to seeding, the scaffolds were pre-
wetted by vacuum impregnation with culture medium for 2 hours in standard cell culture conditions after which they were 
dried in a non-humidified incubator overnight (Papantoniou et al. 2013).  
1.2.3. Viscosity measurements culture medium 
The viscosity of the culture medium was increased by the addition of dextran (average MW 150,000, Sigma). The viscosity 
of solutions containing 0, 2.5, 5, 7.5 and 10% dextran was determined using a MCR 501 rheometer (Anton Paar). A C-
LTD 180/XL measurement chamber was used to enable shear stress measurements at a constant temperature of 37°C. For 
each measurement the solution was pre-sheared at a shear rate of 100/s for 30 seconds after which a rate sweep from 100/s 
to 0.1/s shear rate was performed using a log ramp. Data points corresponding with torques lower than 0.001 mNm were 
discarded due to inaccuracy of the measurements. Since τ=η*γ (with τ: shear stress, η: viscosity and γ: shear rate) the  
viscosity of the solution could be determined by correlating the applied shear rate to the measured shear stress. 
1.2.4. 2D AB and PB measurements 
For 2D experiments, cells were seeded at the standard density of 5,700 cells/cm² in 6 well plates and cultured statically in 
2 ml of growth medium. For 6 days the metabolic activity of the cells was measured daily using both PB and AB for 3 
wells each (both metabolic assays were obtained from Life Technologies). For both reagents a measurement solution 
containing 1 unit volume of reagent for 10 unit volumes of culture medium was prepared resulting in a 9.09% solution 
(standard concentration measuring solution unless otherwise mentioned). The medium was removed from the wells and 
replaced with 2 ml of the PB or AB solution after which the cells were transferred back to the incubator at normal cell 
culture conditions. At the different incubation times (15, 30, 45, 60, 90 and 120 minutes) a 100 µl sample was taken from 
every well and transferred to a 96-well plate. The fluorescent signal was measured with an automated microplate 
fluorometer (SerColab Systems) using an excitation wavelength of 544 nm and an emission wavelength of 590 nm as 
described earlier (Zhou et al. 2013). The measured fluorescent signal was expressed as arbitrary fluorescent units (FU). 
For every measurement the background signal of the measurement solution was determined by incubating an identical 
volume in the absence of cells in the experimental conditions. This blank signal was subsequently subtracted from the 
signal measured in the presence of cells to obtain the signal induced by the presence of the cells. After the measurement, 
the PB or AB solution was removed from the wells and replaced by normal culture medium. For the measurement on day 
5, 3 ml of the measuring solution was used to allow for a higher number of sampling points. Additional samples were taken 
after 3, 4, 5 and 6 hours of incubation. 
To determine the quantitative correlation between the PB signal and the cell number in a 2D static setting two different 
approaches were used. 6-well plates were seeded with 100,000 cells each and cells were allowed to attach over night after 
which the culture medium was removed and 2, 4 or 6 ml of the PB solution was added on triplicate wells. Cells were 
incubated for 8 hours in total and 100 µl samples were taken every hour and transferred to a 96-well plate for measurement. 
Alternatively, different amounts of cells were seeded in triplicate in 6-well plates (25,000, 50,000, 75,000, 100,000, 
200,000, and 300,000). Cells were incubated overnight to allow cell attachment after which the culture medium was 
removed and 2ml of PB solution was added. Samples were taken every hour for 8 hours and measured as described before.  
1.2.5. 3D static cell culture and PB measurements 
For 3D culture experiments cells were drop-seeded onto the scaffolds at a density of 200,000 cells/60 µl as described in 
previous studies (Papantoniou et al. 2013, Zhou et al. 2013, Papantoniou et al. 2014, Sonnaert et al. 2014). 45 minutes 
after seeding 60 µl culture medium was added and 135 minutes later the medium volume was topped up to 1 ml. Scaffolds 
were statically incubated overnight in standard culture conditions (37°C, 5% CO2, 95% relative humidity). Since the seeding 
process resulted in homogenous and reproducible seeding efficiencies in previous work (~60%) this was not assessed 
separately in this work (Papantoniou et al. 2013, Papantoniou et al. 2014, Sonnaert et al. 2014). 
To determine the quantitative correlation between the PB signal and the cell content in a 3D static culturing system, 
scaffolds were transferred to 12 well plates containing 3 ml of culture medium after seeding. Medium was refreshed every 
two days and PB measurements were performed at day 1, 6, 10, 15 and 22 by replacing the culture medium with 3 ml of 
the PB solution and incubating the scaffolds in standard cell culture conditions for 3 hours. The PB signal was measured 
in triplicate as described before. At each PB time point 3 scaffolds were sacrificed for DNA measurement as described 
below. 
1.2.6. 3D perfusion bioreactor culture and PB measurement 
For 3D perfusion bioreactor culture, 3D Ti6Al4V scaffolds were seeded in the bioreactor system using the same methods 
as described for the static system (Papantoniou et al. 2013, Papantoniou et al. 2014, Sonnaert et al. 2014). Scaffolds were 
subsequently press-fitted in an in-house developed bioreactor chamber  (Papantoniou et al. 2013, Zhou et al. 2013, 
Papantoniou et al. 2014, Sonnaert et al. 2014) ensuring forced perfusion through the scaffold and cultured at a flow rate of 
1 ml/min in a non-humidified incubator (37°C, 5% CO2). The total medium volume in each circuit was 10 ml of which 7.2 
ml was located in the medium reservoir. Medium was refreshed every second day by attaching a falcon tube containing 
fresh medium to the system. For PB measurements a falcon tube containing 2.2 ml of a 20.5% PB solution was connected 
to the circuit resulting in a total volume of 5 ml and a final PB concentration of 9.09% as used for the static measurements. 
The PB solution was perfused for one hour at 1 ml/min after which the resulting PB signal in the solution was measured. 
To remove remnants of the PB solution in the bioreactor circuits for continued cell culture two falcon tubes containing 5 
ml of culture medium were subsequently connected to the circuits for a perfusion step of 5 minutes each after which a final 
medium refreshment was performed as described before. After seeding the scaffolds were dynamically cultured for 21 days 
and PB measurements were performed in triplicate on day 2, 7, 12, 17 and 21. After each PB measurement 3 scaffolds were 
sacrificed for DNA measurement. 
To determine the influence of both culture the measurement setup (static versus bioreactor), 3D cell seeded scaffolds 
cultured for 14 days in both systems were measured either in the respective culture systems or consecutively both in a static 
and perfusion bioreactor setup. All conditions were performed and measured in triplicate. In an additional 3 samples 
cultured in both setups no PB measurements were performed to verify that the performed handlings had no influence on 
cell number. All samples were used for DNA measurement after the experiment.   
To determine the influence of different flow rates during 3D perfusion bioreactor culture on the metabolic activity of cells 
in the 3D scaffolds, and thereby on the conversion rates of the PB, they were cultured at different flow rates (0.5 ml/min, 
1.1 ml/min and 2.2 ml/min) for 21 days after which the metabolic activity of the cells was determined using PB. The flow 
rates used during the PB measurement were the same as those used during culture for all conditions. The cell content of 
the scaffolds was also determined based on DNA measurements. Additionally, two conditions in which the volumetric flow 
rate was 0.5ml/min but the shear stress was equal to respectively the 1.1 and 2.2 ml/min condition by increasing the 
viscosity of the medium as described earlier (Section 2.3) using respectively 3.37% and 6.36% dextran (average MW 
150,000, Sigma) were evaluated.     
1.2.7. DNA measurement 
The DNA content was determined using a highly quantitative and selective DNA assay (Quant-iTTM dsDNA HS kit, Life 
Technologies). The scaffolds were rinsed with PBS and lysed in 350 µl RLT lysis buffer supplemented with 3.5 µl β-
mercaptoethanol (Qiagen). The lysed samples were vortexed for 60 seconds and stored at -80°C prior to analysis, thawed 
at room temperature and spun down for 1 min at 13,000 rpm. 10 µl of the sample was diluted in 90 µl milliQ water after 
which the DNA content was quantified with a Qubit® Fluorometer (Life Technologies) as described by Chen et al., 2012 
(Chen et al. 2012) 
1.2.8. Mathematical representation of the PB measurement in the perfusion bioreactor 
system using ordinary differential equations 
A schematic representation of the bioreactor system is shown in Figure.1. The concentration of the resorufin in the medium 
reservoir could be determined based on a mass balance over the reservoir taking into account the flow rate dependent in 
and outward fluxes (eq. 1). The outward flux was defined based on the flow rate and the resorufin concentration (eq. 2). 
The inward flux in the medium reservoir was equal to the outward flux at the scaffold although a flow rate and tubing 
volume dependent time delay had to be implemented to account for the time the measurement suspension required to be 
perfused from the scaffold back to the medium reservoir (eq. 3). The flux at the outlet of the scaffold was determined by 
the ingoing flux and the cell mediated resazurin conversion (eq.4) while the flux at the inlet of the scaffold was defined 
based on the concentration in the medium reservoir, again implementing the flow rate and tubing volume dependent time 
delay in order to account for the time required to perfuse the solution from the medium reservoir to the scaffold (eq.5). 
At the initial time point the resorufin concentration in the medium reservoir was set at zero while the maximal value was 
set at 3 500 as these were determined to be the borders of the linear operating window.  
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Figure.1: Schematic representation of the perfusion bioreactor system (Adapted from Zhou et al., 2013) 
1.2.9. Statistical analysis 
One-way Anova was performed to analyse significant differences between groups. A p-value < 0.05 was considered 
significant. 
 
1.3. Results 
Initially the PB metabolic assay was compared with the previously validated AB assay (Zhou et al. 2013) by monitoring 
for both assays cell proliferation in a static 2D setup for different incubation times (Figure.2.A and B). Both metabolic 
assays showed an increase in metabolic activity in function of culture time.in accordance with the expected exponential 
phase of cell growth. Although the same incubation times and concentrations were used, the PB signal was significantly 
higher compared to the AB signal for the same incubation time. This was also visible by the stronger increase in signal 
shown in Figure.2.C in which the linear operating window of both assays was determined respectively up to 3,000 FU for 
the AB assay and 3,500 for the PB assay. The relative standard deviation on the measured signal was also significantly 
lower for the PB measurement as shown in Figure.2.D. 
 Figure.2: (A, B) 2D static expansion of hPDCs monitored with Alamar blue and Presto Blue respectively for different 
incubation times (n=3) (C) Signal saturation determined for Presto Blue and Alamar Blue based on 2D static expansion. 
The lines indicate the linear operating zone for both assays (R² values are shown for a fit forced through 0;0) (n=3) (D) 
Boxplot of relative standard deviation for 2D static Presto Blue and Alamar Blue measurements (n=60) 
Conversion rates for PB were determined in a static setup for both 2D and 3D cell culture systems. For all conditions a 
time dependent linear increase in the measured signal was observed (Figure 3). Linear regression was used to determine 
the slope coefficients which indicated the increase in FU per hour for all different conditions (Table1). These values were 
corrected for incubation time, cell number and volume and were then averaged over the different experimental conditions. 
For the case of 2D cell culture the two different setups used to determine the conversion rate resulted in a similar average 
value of approximately 616 FU converted per hour for 100,000. For the measurement in the 3D static culture system a 
linear correlation was again observed between the PB obtained signal and the cell number based on DNA measurement as 
shown in Figure 3.C. The resulting PB conversion rate was however significantly lower than the one obtained for the 2D 
static system (Table1).  
 Table1: Observed increase in Presto Blue signal per hour for different static culture conditions based on Figure 3 and the 
representative Presto Blue conversion rates. 
 
Figure 3: (A) Fluorescent signal measured for different volumes of Presto Blue solution for 100,000 cells in a 2D static 
setup (n=3) (B) Fluorescent signal measured for different cell numbers in 2ml Presto Blue solution in a 2D static setup 
(n=3) (C) Presto Blue signal in function of incubation time for different time points during 3D static culture and 
corresponding cell number based on DNA measurements (n=3)  
As shown for both the 2D and 3D static culture and measurement setups the PB signal and DNA content measured for 
perfusion bioreactor expanded cells showed no significant differences after fitting the curves as shown in Figure 4.A in 
which both the increase in FU and the increase in cell number are represented on the Y-axis. Normalizing the signal to the 
volume and cell number resulted in conversion rates which were not significantly different from the earlier determined 2D 
conversion rates during the proliferative phase (Figure 4.B). As also shown in Figure 4.A the metabolic conversion rate of 
the cells in the scaffold does decrease once confluency is reached as determined with DNA measurements (Figure 4.B). 
 
Figure 4: (A) Cell number and Presto Blue signal during 21 days of 3D perfusion bioreactor culture for different time points 
(B) Presto Blue conversion rates for different time points during 3D perfusion bioreactor culture. * 0.05<p<0.01 
In order to determine the influence of the culture and measurement setup on the PB signal, bioreactor and static 
measurements of cells expanded in both 3D bioreactor and static setups were performed. Figure.5.A shows a significant 
higher DNA content for all 3D bioreactor expanded cells in comparison to the static 3D expanded cells. No significant 
difference was observed between the cells expanded under the same conditions indicating that the handlings performed for 
the measurements did not influence the cell content. Despite the significant differences observed in DNA content no 
differences in PB signal were observed between the 3D static and bioreactor expanded cells using the static measurement 
setup (Figure.5.C). However the measurements performed in the bioreactor system showed a significant difference between 
the bioreactor and the statically expanded cells (Figure.5.B). Since different incubation times and PB volumes were used 
for the bioreactor and static measurements the obtained signal was corrected for cell number, time and volume. Figure.5.D 
shows that a similar conversion rate was determined for all bioreactor measured conditions, independently from the culture 
setup. The conversion rate determined for static measurements were significantly lower in comparison to all bioreactor 
measured conditions. Additionally, the conversion rate determined for the bioreactor cultured, static measured samples was 
significantly lower than those for the statically cultured and measured.  
 Figure.5: (A) DNA content (ng/ml) after 3D cell expansion for  different culture and measurement setups, as shown on the 
axis (n=3) (B) Presto Blue signal after either 3D static or perfusion bioreactor cell expansion, measured in the perfusion 
bioreactor system  (n=3) (C) Presto Blue signal after either 3D static or perfusion bioreactor cell expansion, measured in 
the static system (n=3) (D) Conversion rates for 3D constructs cultured in a bioreactor or static setup determined using a 
bioreactor (black) or static (grey) measurement setup (n=3). * 0.05<p<0.01, ** 0.01<p<0.001, $ indicates significant 
differences between dynamic and static measurement for the same construct, p<0.05 
No significant differences in cell proliferation were observed when using different flow rates nor did the increased viscosity 
and the correlated shear stress for the low volumetric perfusion influence the final cell number (Figure.6.A). Additionally, 
the conversion rates determined for the different conditions were not influenced by the perfusion velocity (Figure.6.B) 
indicating that, next to the proliferation, the PB conversion rates and therefore the metabolic activity of the cell population, 
was not influenced by flow rate within the examined range corresponding with initial shear stress values between 7E-3 Pa 
and 3.08E-2 Pa (Sonnaert et al. 2014). 
Although flow rate does not influence the conversion rate of the PB assay it should be high enough to prevent local 
saturation of the assay at the outlet of the scaffold. To determine at which combinations of flow rate and cell number this 
could influence the readouts, mass balance equations were used to determine the relative saturation of the linear PB 
operating window in the medium reservoir and at the scaffold in- and outlet in function of flow rate, cell number, 
measurement volume and incubation time. The resulting resorufin concentrations at the scaffold outlet obtained from the 
time dependent mass balances were subsequently converted to relative PB saturation as shown in Figure.7.A-C. Although 
flow rate did not influence the conversion rate of the assay, flow rate dependent changes in PB saturation were observed 
(Figure.7.B). Figure.7.D subsequently shows for which combinations of incubation time, cell number and flow rate 
saturation at the scaffold outlet is reached, allowing to define an operating window for the measurement.  
 Figure.6: (A) Cell content for 3D constructs cultured in the perfusion bioreactor based on DNA measurement for different 
flowrates and medium viscosities (n=3) (B) Presto Blue conversion rate for 3D constructs cultured in the perfusion 
bioreactor with different flowrates and medium viscosities 
 
Figure.7: Presto Blue saturation at the bioreactor chamber outlet determined for (A) different cell numbers (B) different 
flow rates (ml/min) (C) different measurement volumes (ml) (D) incubation time (min) after which saturation of the Presto 
Blue assay is reached at the bioreactor chamber outlet for specific combinations of cells and flow rate (ml/min) (E) 
Operating window for Presto Blue measurement of a bioreactor chamber containing a scaffold with 2,500,000 cells valid 
for flow rates above 0.4ml/min (F) Operating window for a Presto Blue measurement in a 3D perfusion bioreactor system 
containing 5ml of measurement solution valid for flow rates above 0.4ml/min. The red area shows the measurement 
conditions which result in a value outside the linear operating window of the assay. 
1.4. Discussion 
A number of reports have shown that metabolic assays such as the AB assay can be used to monitor cell proliferation 
(Mueller et al. 2013, Zhou et al. 2013) although no quantitative correlation between the conversion rate of the reagent and 
the cell number has been defined. To enable a quantitative use of this tool we investigated the influence of three different 
cell culture methods and correlated measurement set-ups, including bioreactor culture, on the conversion of the resazurin 
based PB metabolic assay.  
Initially, a validated metabolic activity assay, the AB assay (Zhou et al. 2013) was compared with the PB assay for 
conventional 2D cell expansion. As shown in Figure.2.C the maximum signal obtained in the linear operating range was 
approximately 3,000 FU for the AB assay and 3,500 for the PB assay indicating that the latter has a significantly larger 
operating window.  Additionally, the time dependent increase in signal was significantly higher at each time point for the 
PB (Figure.2.A, B and C) demonstrating that this assay has a higher sensitivity power which was also confirmed by 
comparing the relative standard deviations obtained for both assays (Figure.2.D).  
Table1 shows that a linear correlation between PB signal and cell content exists (R²=0.87). Due to the increase in cell 
number, and the correlated decrease in available surface for proliferation, a decreasing trend in PB conversion in function 
of cell number was however present.  Nonetheless, no significant differences were observed between the average 
conversion rates determined using different volumes and cell numbers and a quantitative correlation between cell number 
and PB signal could be established. Although other groups reported discrepancies between resazurin conversion of the AB 
assay and cell number (Ng et al. 2005, Quent et al. 2010) these could probably have been induced by the high cell density 
in the culture systems used. When performing a similar experiment for static 3D cell culture and monitoring proliferation 
in function of time a quantitative relation between cell number and PB signal was again observed (Figure 3.C) although a 
significantly lower conversion rate was obtained (Table1). For the perfusion bioreactor 3D cell culture, the PB conversion 
rate was significantly higher than observed for the static 3D system and no difference was found in relation to the 2D setup 
(Figure 4.B). Since previous studies already showed that cell growth in 3D scaffolds in a static culture setup is 
predominantly located at the outer edges of the scaffolds due to limitations in nutrient diffusion (Ishaug et al. 1997, Bancroft 
et al. 2002, Sikavitsas et al. 2003, Papantoniou et al. 2014, Sonnaert et al. 2014) also the difference in PB conversion rate 
might be related to limited diffusion.  
In order to confirm that the different conversion rates observed between 3D static and perfused culture systems originated 
from enhanced mass transport in the perfusion bioreactor system, the conversion rate for cells expanded both in the 3D 
static or bioreactor system were determined using both static and bioreactor measurement setups. As shown in Figure.5.A 
the measurement methods and manipulations did not influence the final cell content of the scaffolds. Despite the significant 
differences in DNA content, the PB signal measured in the static setup was not influenced by the culture conditions 
(Figure.5.C). Diffusion limitations possibly influenced the accessibility of the cells in the centre of the densely populated 
bioreactor cultured scaffolds (Ishaug et al. 1997, Bancroft et al. 2002, Sikavitsas et al. 2003). In order to confirm this 
hypothesis the maximal diffusion depth of the resazurin in the scaffolds was determined using a partial differential equation 
describing the spatiotemporal evolution of resazurin (cR) as discussed by Demol et al., 2011 (Demol et al. 2011). As no 
data was available on resazurin diffusion in an engineered neo-tissue the diffusion coefficient (D) of resazurin in aquatic 
systems was used as an approximation (2.04*10-6cm²/s) (Khazalpour et al. 2014). The resazurin conversion rate (Q) was 
based on the results discussed earlier and cells were assumed to be homogenously distributed in the neo-tissue with a 
density (ccell) based on previous nano-CT volumetric results (Papantoniou et al. 2014, Sonnaert et al. 2014).  
𝜕𝑐𝑅(𝑧, 𝑟, 𝑡)
𝜕𝑡
= 𝐷(𝑧, 𝑟, 𝑡). ∇2c𝑅(𝑧, 𝑟, 𝑡) − 𝑄 ∗ 𝑐𝑐𝑒𝑙𝑙(𝑧, 𝑟, 𝑡) 
The steady state solution of the system enabled determining a maximal diffusion depth of 700µm. This results in an active 
volume of 40% of the total scaffold implying that only the cells present in this volume can contribute to the resazurin 
conversion. This corresponds to the discrepancy between the apparent conversion rate determined for bioreactor cultured, 
static measured scaffolds and bioreactor cultured and measured scaffolds in which the resasurin is perfused through the 
scaffold for which the static determined conversion rate was only 35% of the dynamic based value (Figure.5.D). For the 
bioreactor measured conditions we did observe an influence of the culture system on PB conversion (Figure.5.B). To 
compare conversion rates between the two measurement setups the PB signal was corrected for volume, time and cell 
number (Figure.5.D) which showed that conversion rates measured with the bioreactor setup were not influenced by the 
culture system used. As the Péclet number was larger than 1, the convective mass transport in this measurement setup 
ensured a homogeneous distribution of the PB reagent throughout the scaffold independent from the cell distribution and 
therefore a realistic conversion rate could be determined as opposed to apparent conversion rates obtained in the static, 
diffusion based setups. Since the used culture systems did not influence the conversion rates, the differences observed 
between the static and bioreactor measurement setups were not caused by changes in cell metabolic activity but rather by 
a decreased conversion efficiency caused by diffusion limitations (Ishaug et al. 1997, Bancroft et al. 2002, Sikavitsas et al. 
2003). Despite the lower conversion rate in the static setup a correlation between the obtained PB signal and the DNA 
content still exists as shown in Figure 3.C. This indicates that dependent on the measurement system different conversion 
rates should be used and that quantitative use of the methodology requires a system specific validation of the measurement. 
This was further validated by generating a correlation plot depicting the cell number based on the PB measurements in 
function of the cell number based on DNA measurements (Figure.8). Taking into account the respective conversion rates 
for the static cultured/measured and dynamic cultured/measured expansion systems an R² value of 0.9548 was obtained 
confirming the potential quantitative use of the methodology. 
 Figure.8: Correlation between cell number determined on DNA measurement and cell number based on Presto Blue 
measurement for all 3D static and dynamic cell expansion performed for Figures 2-6 using the respective conversion rates 
determined for the two culture systems. (▲ 3D dynamic expansion and measurement, ● 3D static expansion and 
measurement) 
At day 21 of culture, after the proliferative phase as could be observed in Figure 4.A, both the increase in cell content, the 
PB signal and the conversion rate decreased significantly. As suggested for the 2D system (Figure 3.B and Table1) the 
decreased conversion rate of the PB assay for high cell densities might be related to the decrease in cell proliferation. 
Alternatively, previous work showed a non-linear correlation between the resazurin conversion and the cell number for 
high density cell cultures which was due to diffusion limitations both in 2D and 3D (Ng et al. 2005), although the fluid 
flow in the bioreactor system should circumvent these problems. Additionally, the high cell density in these constructs has 
been suggested to result in the further reduction of the fluorescent resorufin in the non-fluorescent, colourless 
hydroresorufin (O'Brien et al. 2000) thereby resulting in a decreased amount of the fluorescent resorufin. However, since 
multiple groups showed a linear behaviour of the assay within the defined operating conditions (Quent et al. 2010, Mueller 
et al. 2013, Zhou et al. 2013), the decrease in cell proliferation remains the most probable explanation for the observed 
decreased conversion rate of the PB.  
In order to determine the applicability of the proposed methodology for a broader range of operating conditions we 
subsequently also determined the influence of the use of different flow rates and shear stresses (using dextran to increase 
fluid viscosity) on the metabolic conversion rates of the assay. In a recent publication we showed that the use of range of 
flow rates (corresponding to initial shear stress values between 5.59E-4 and 5.59E-2Pa) did not induce differentiation of 
the expanding hPDC cell population (Sonnaert et al. 2014) Furthermore, a functional bone marrow derived mesenchymal 
cell population was also expanded in undifferentiated state under flow conditions in a perfusion 
bioreactor(Papadimitropoulos et al. 2014). In correspondence with these findings, we observed that the metabolic activity 
of the hPDCs is constant and independent from dextran concentration (affecting shear stress) and volumetric flow rate. 
Taking into account the determined conversion rates, expected number of cells and the culture and measurement setup 
these results now allow to define an operating window for each specific setup which will allow a rational selection of 
operating conditions (Gerontas et al. 2009, Papantoniou et al. 2013). Figure.7.D shows for which combination of cell 
number, flow rate and incubation time saturation of the assay is reached at the scaffold outlet, thus indicating the minimal 
flow rate and maximal incubation time required for monitoring an expansion system in function of the expected maximal 
cell number. It should be noted that, despite the fixed assay volume and therefore the fixed amount of resazurin which can 
be converted, the maximal incubation time for a certain cell number varies in function of flow rate. Next to the saturation 
of the assay due to high cell numbers and low flow rates, a significant resazurin concentration gradient will be present in 
the tubing of the system for high cell numbers and low flow rates. For higher flow rates this concentration gradient will be 
negligible resulting in a constant, cell dependent maximal incubation time. For these cases the operating window of the 
assay can be determined based on the total circuit volume, incubation time and expected cell number as shown in Figure.7.E 
and F in which the expected PB signal is shown in function of measurement volume and incubation time (Figure.7.E) or 
incubation time and cell number (Figure.7.F). This simplified representation of the system will be valid for flow rates that 
not significantly influence the maximal incubation time as shown in Figure.7.D. Next to using this mathematical 
representation of the system to define optimal operating conditions, the quantitative correlation between PB conversion 
and cell number can also be used to determine the cell number in the scaffold at any given time. Additionally, the theoretical 
boundaries of the window of operation could be determined for the dynamic measurement method i.e. convective perfusion 
through the constructs. For example, using a flow rate of 1ml/min as employed for measurements in this study, cell numbers 
as low as 50.000 cells could be detected using 5ml of PB solution although at least 120 minutes incubation time would be 
required to obtain a quantitative signal. On the other hand, using the same flow rate and 50ml of PB solution, constructs 
containing up to 25.000.000 cells could be monitored using short incubation times between 15 and 20 minutes. A further 
increase in PB solution volume would even allow the further broadening of the window of operations, thereby enabling the 
methodology to effectively cover the entire range of cell densities used for tissue engineering applications for which final 
cell densities in the engineered constructs were reported between 10^7 and 10^8 cells/cm³  (Bancroft et al. 2002, Eyckmans 
et al. 2006, Haycock 2011, Rodrigues et al. 2011, Santoro et al. 2012).In conclusion we can state that the PB assay is a 
promising tool to for on-line monitoring of cell proliferation in a 3D perfusion bioreactor system. Since the conversion of 
the metabolic assay was shown to be constant in function of time during cell proliferation, and the culture parameters such 
as flow rate and shear stress did not influence the metabolic activity nor the conversion efficiency, a quantitative correlation 
between cell number and PB conversion could be established. This allowed to determine the assay concentration at each 
location in the setup, thereby enabling to define optimal operating conditions as well as calculating cell number in the 
scaffold based on the PB concentration.  
1.5. Acknowledgements  
MS is supported by a Ph.D. grant of the Agency for Innovation by Science and Technology (IWT/ 111457). IP is funded 
by the ENDEAVOUR project G.0982.11N of the Research Foundation Flanders (FWO Vlaanderen). This work is part of 
Prometheus, the Leuven Research & Development Division of Skeletal Tissue Engineering of the KU Leuven: 
www.kuleuven.be/prometheus 
 
 
 
Back, S. A., R. Khan, X. Gan, P. A. Rosenberg and J. J. Volpe (1999). "A new Alamar Blue viability assay to rapidly 
quantify oligodendrocyte death." J Neurosci Methods 91(1-2): 47-54. 
Bancroft, G. N., V. I. Sikavitsas, J. van den Dolder, T. L. Sheffield, C. G. Ambrose, J. A. Jansen and A. G. Mikos 
(2002). "Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts 
in a dose-dependent manner." Proc Natl Acad Sci U S A 99(20): 12600-12605. 
Chen, Y. T., M. Sonnaert, S. J. Roberts, F. P. Luyten and J. Schrooten (2012). "Validation of a PicoGreen-Based 
DNA Quantification Integrated in an RNA Extraction Method for Two-Dimensional and Three-Dimensional Cell 
Cultures." Tissue Engineering Part C-Methods 18(6): 444-452. 
Chew, W. and P. Sharratt (2010). "Trends in process analytical technology." Analytical Methods 2(10): 1412-1438. 
Cui, Z. F., X. Xu, N. Trainor, J. T. Triffitt, J. P. Urban and U. K. Tirlapur (2007). "Application of multiple parallel 
perfused microbioreactors and three-dimensional stem cell culture for toxicity testing." Toxicol In Vitro 21(7): 
1318-1324. 
Das, R. H., G. J. van Osch, M. Kreukniet, J. Oostra, H. Weinans and H. Jahr (2010). "Effects of individual control of 
pH and hypoxia in chondrocyte culture." J Orthop Res 28(4): 537-545. 
Demol, J., D. Lambrechts, L. Geris, J. Schrooten and H. Van Oosterwyck (2011). "Towards a quantitative 
understanding of oxygen tension and cell density evolution in fibrin hydrogels." Biomaterials 32(1): 107-118. 
Eyckmans, J. and F. P. Luyten (2006). "Species specificity of ectopic bone formation using periosteum-derived 
mesenchymal progenitor cells." Tissue Eng 12(8): 2203-2213. 
Frese, J., A. Morgenroth, M. E. Mertens, S. Koch, L. Rongen, A. T. Vogg, B. D. Zlatopolskiy, B. Neumaier, V. N. 
Gesche, T. Lammers, T. Schmitz-Rode, P. Mela, S. Jockenhoevel, F. M. Mottaghy and F. Kiessling (2014). 
"Nondestructive monitoring of tissue-engineered constructs." Biomed Tech (Berl) 59(2): 165-175. 
Gerontas, S., S. S. Farid and M. Hoare (2009). "Windows of Operation for Bioreactor Design for the Controlled 
Formation of Tissue-Engineered Arteries." Biotechnology Progress 25(3): 842-853. 
Gloeckner, H., T. Jonuleit and H. D. Lemke (2001). "Monitoring of cell viability and cell growth in a hollow-fiber 
bioreactor by use of the dye Alamar Blue." J Immunol Methods 252(1-2): 131-138. 
Grayson, W. L., T. Ma and B. Bunnell (2004). "Human mesenchymal stem cells tissue development in 3D PET 
matrices." Biotechnol Prog 20(3): 905-912. 
Haycock, J. W. (2011). "3D cell culture: a review of current approaches and techniques." Methods Mol Biol 695: 
1-15. 
Ishaug, S. L., G. M. Crane, M. J. Miller, A. W. Yasko, M. J. Yaszemski and A. G. Mikos (1997). "Bone formation by 
three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds." J Biomed Mater Res 36(1): 
17-28. 
Jakob, M., F. Saxer, C. Scotti, S. Schreiner, P. Studer, A. Scherberich, M. Heberer and I. Martin (2012). "Perspective 
on the Evolution of Cell-Based Bone Tissue Engineering Strategies." European Surgical Research 49(1): 1-7. 
Kerckhofs, G., G. Pyka, M. Moesen, S. Van Bael, J. Schrooten and M. Wevers (2013). "High-Resolution Microfocus 
X-Ray Computed Tomography for 3D Surface Roughness Measurements of Additive Manufactured Porous 
Materials." Advanced Engineering Materials 15(3): 153-158. 
Khazalpour, S. and D. Nematollahi (2014). "Electrochemical study of Alamar Blue (resazurin) in aqueous solutions 
and room-temperature ionic liquid 1-butyl-3-methylimidazolium tetrafluoroborate at a glassy carbon electrode." 
Rsc Advances 4(17): 8431-8438. 
Martin, I., H. Baldomero, C. Bocelli-Tyndall, J. Passweg, D. Saris and A. Tyndall (2012). "The Survey on Cellular and 
Engineered Tissue Therapies in Europe in 2010." Tissue Engineering Part A 18(21-22): 2268-2279. 
Martin, I., H. Baldomero, C. Bocelli-Tyndall, I. Slaper-Cortenbach, J. Passweg and A. Tyndall (2011). "The survey 
on cellular and engineered tissue therapies in europe in 2009." Tissue Eng Part A 17(17-18): 2221-2230. 
Martin, I., S. A. Riboldi and D. Wendt (2010). Bioreactor Systems in Regenerative Medicine. Advances in 
Regenerative Medicine: Role of Nanotechnology, and Engineering Principles. Dordrecht, The Netherlands, 
Springer Science+Business Media: 95-113. 
Martin, I., D. Wendt and M. Heberer (2004). "The role of bioreactors in tissue engineering." Trends in 
Biotechnology 22(2): 80-86. 
Mueller, D., G. Tascher, G. Damm, A. K. Nussler, E. Heinzle and F. Noor (2013). "Real-time in situ viability 
assessment in a 3D bioreactor with liver cells using resazurin assay." Cytotechnology 65(2): 297-305. 
Ng, K. W., D. T. W. Leong and D. W. Hutmacher (2005). "The challenge to measure cell proliferation in two and 
three dimensions." Tissue Engineering 11(1-2): 182-191. 
Nociari, M. M., A. Shalev, P. Benias and C. Russo (1998). "A novel one-step, highly sensitive fluorometric assay to 
evaluate cell-mediated cytotoxicity." J Immunol Methods 213(2): 157-167. 
O'Brien, J., I. Wilson, T. Orton and F. Pognan (2000). "Investigation of the Alamar Blue (resazurin) fluorescent dye 
for the assessment of mammalian cell cytotoxicity." Eur J Biochem 267(17): 5421-5426. 
Papadimitropoulos, A., E. Piccinini, S. Brachat, A. Braccini, D. Wendt, A. Barbero, C. Jacobi and I. Martin (2014). 
"Expansion of Human Mesenchymal Stromal Cells from Fresh Bone Marrow in a 3D Scaffold-Based System under 
Direct Perfusion." PLoS One 9(7). 
Papantoniou, I., Y. C. Chai, F. P. Luyten and J. Schrooten (2013). "Process quality engineering for bioreactor-driven 
manufacturing of tissue engineered constructs for bone regeneration." Tissue Eng Part C Methods 19(8): 596-
609. 
Papantoniou, I., M. Sonnaert, L. Geris, F. P. Luyten, J. Schrooten and G. Kerckhofs (2014). "Three-dimensional 
characterization of tissue-engineered constructs by contrast-enhanced nanofocus computed tomography." 
Tissue Eng Part C Methods 20(3): 177-187. 
Pyka, G., A. Burakowski, G. Kerckhofs, M. Moesen, S. Van Bael, J. Schrooten and M. Wevers (2012). "Surface 
Modification of Ti6Al4V Open Porous Structures Produced by Additive Manufacturing." Advanced Engineering 
Materials 14(6): 363-370. 
Quent, V. M. C., D. Loessner, T. Friis, J. C. Reichert and D. W. Hutmacher (2010). "Discrepancies between 
metabolic activity and DNA content as tool to assess cell proliferation in cancer research." Journal of Cellular and 
Molecular Medicine 14(4): 1003-1013. 
Quinn, K. P., E. Bellas, N. Fourligas, K. Lee, D. L. Kaplan and I. Georgakoudi (2012). "Characterization of metabolic 
changes associated with the functional development of 3D engineered tissues by non-invasive, dynamic 
measurement of individual cell redox ratios." Biomaterials 33(21): 5341-5348. 
Rampersad, S. N. (2012). "Multiple applications of Alamar Blue as an indicator of metabolic function and cellular 
health in cell viability bioassays." Sensors (Basel) 12(9): 12347-12360. 
Rauh, J., F. Milan, K. P. Gunther and M. Stiehler (2011). "Bioreactor Systems for Bone Tissue Engineering." Tissue 
Engineering Part B-Reviews 17(4): 263-280. 
Rebulla, P., T. Montemurro and R. Giordano (2010). "Regulation of cell-based medicine: the European 
experience." State of the Art Presentations 5(1): 249-251 
323. 
Rice, W. L., D. L. Kaplan and I. Georgakoudi (2010). "Two-Photon Microscopy for Non-Invasive, Quantitative 
Monitoring of Stem Cell Differentiation." PLoS One 5(4). 
Rodrigues, C. A. V., T. G. Fernandes, M. M. Diogo, C. L. da Silva and J. M. S. Cabral (2011). "Stem cell cultivation 
in bioreactors." Biotechnology Advances 29(6): 815-829. 
Salter, E., B. Goh, B. Hung, D. Hutton, N. Ghone and W. L. Grayson (2012). "Bone Tissue Engineering Bioreactors: 
A Role in the Clinic?" Tissue Eng Part B Rev 18(1): 62-75. 
Santoro, R., C. Krause, I. Martin and D. Wendt (2012). "On-line monitoring of oxygen as a non-destructive method 
to quantify cells in engineered 3D tissue constructs." Journal of Tissue Engineering and Regenerative Medicine 
6(9): 696-701. 
Schneider, C. K., P. Salmikangas, B. Jilma, B. Flamion, L. R. Todorova, A. Paphitou, I. Haunerova, T. Maimets, J. H. 
Trouvin, E. Flory, A. Tsiftsoglou, B. Sarkadi, K. Gudmundsson, M. O'Donovan, G. Migliaccio, J. Ancans, R. 
Maciulaitis, J. L. Robert, A. Samuel, J. H. Ovelgonne, M. Hystad, A. M. Fal, B. S. Lima, A. S. Moraru, P. Turcani, R. 
Zorec, S. Ruiz, L. Akerblom, G. Narayanan, A. Kent, F. Bignami, J. G. Dickson, D. Niederwieser, M. A. Figuerola-
Santos, I. G. Reischl, C. Beuneu, R. Georgiev, M. Vassiliou, A. Pychova, M. Clausen, T. Methuen, S. Lucas, M. 
Schussler-Lenz, V. Kokkas, Z. Buzas, N. MacAleenan, M. C. Galli, A. Line, J. Gulbinovic, G. Berchem, M. Fraczek, M. 
Menezes-Ferreira, N. Vilceanu, M. Hrubisko, P. Marinko, M. Timon, W. Cheng, G. A. Crosbie, N. Meade, M. L. di 
Paola, T. VandenDriessche, P. Ljungman, L. D'Apote, O. Oliver-Diaz, I. Buttel and P. Celis (2010). "Challenges with 
advanced therapy medicinal products and how to meet them." Nat Rev Drug Discov 9(3): 195-201. 
Sikavitsas, V. I., G. N. Bancroft, H. L. Holtorf, J. A. Jansen and A. G. Mikos (2003). "Mineralized matrix deposition 
by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces." Proc Natl 
Acad Sci U S A 100(25): 14683-14688. 
Sonnaert, M., I. Papantoniou, V. Bloemen, G. Kerckhofs, F. P. Luyten and J. Schrooten (2014). "Human periosteal-
derived cell expansion in a perfusion bioreactor system: proliferation, differentiation and extracellular matrix 
formation." J Tissue Eng Regen Med. 
Tsao, Y. S., A. G. Cardoso, R. G. G. Condon, M. Voloch, P. Lio, J. C. Lagos, B. G. Kearns and Z. Liu (2005). "Monitoring 
Chinese hamster ovary cell culture by the analysis of glucose and lactate metabolism." Journal of Biotechnology 
118(3): 316-327. 
Uzunoglu, S., B. Karaca, H. Atmaca, A. Kisim, C. Sezgin, B. Karabulut and R. Uslu (2010). "Comparison of XTT and 
Alamar blue assays in the assessment of the viability of various human cancer cell lines by AT-101 (-/- gossypol)." 
Toxicol Mech Methods 20(8): 482-486. 
Van Bael, S., G. Kerckhofs, M. Moesen, G. Pyka, J. Schrooten and J. P. Kruth (2011). "Micro-CT-based improvement 
of geometrical and mechanical controllability of selective laser melted Ti6Al4V porous structures." Materials 
Science and Engineering a-Structural Materials Properties Microstructure and Processing 528(24): 7423-7431. 
Zhou, X., I. Holsbeeks, S. Impens, M. Sonnaert, V. Bloemen, F. P. Luyten and J. Schrooten (2013). "Non-invasive 
real-time monitoring by alamarBlue(R) during in vitro culture of 3D tissue engineered bone constructs." Tissue 
Eng Part C Methods 19(9): 720-729. 
 
